Daclatasvir is an HCV NS5A protein inhibitor for hepatitis C virus research
**Background** Hepatitis C virus (HCV) is a major cause of chronic liver disease, cirrhosis, and hepatocellular carcinoma worldwide. The HCV genome encodes several non-structural proteins essential for viral replication, among…